| Pharmaceutical Information |
| Drug Name |
Valdecoxib |
| Drug ID |
BADD_D02325 |
| Description |
Valdecoxib was removed from the Canadian, U.S., and E.U. markets in 2005 due to concerns about a possible increased risk of heart attack and stroke. |
| Indications and Usage |
For the treatment of osteoarthritis and dysmenorrhoea |
| Marketing Status |
Discontinued |
| ATC Code |
M01AH03 |
| DrugBank ID |
DB00580
|
| KEGG ID |
D02709
|
| MeSH ID |
C406224
|
| PubChem ID |
119607
|
| TTD Drug ID |
D0L6DA
|
| NDC Product Code |
Not Available |
| Synonyms |
valdecoxib | Bextra | SC 65872 | SC-65872 |
|
| Chemical Information |
| Molecular Formula |
C16H14N2O3S |
| CAS Registry Number |
181695-72-7 |
| SMILES |
CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
